Julia Bonavitacola

Clinical trials for diabetic macular edema (DME) continue to see disparities in enrollment.

Attendees and experts from the Southeastern Educational Congress of Optometry (SECO) 2025 meeting highlight research and sessions they will take away.

A survey of HIV health care providers in the US revealed the various approaches that providers took for prescribing antiretroviral therapy (ART).

Brianna Rhue, OD, FAAO, discusses the pitfalls of myopia treatment and accessibility of that treatment.

Brianna Rhue, OD, FAAO, discussed novel approaches to myopia management and how they can be implemented into clinical practice.

Multimodal imaging is a useful tool in diagnosing and managing age-related macular degeneration (AMD), according to Julie Rodman, OD, MS, FAAO.

Nate Lighthizer, OD, FAAO, discusses laser therapy and how attendees at Southeastern Educational Congress of Optometry (SECO) 2025 got hands-on experience at the conference.

Mile Brujic, OD, FAAO, discusses his new research being presented at the Southeastern Educational Congress of Optometry 2025 meeting concerning dry eye treatment.

The cause of age-related macular degeneration can be varied and symptoms are often not recognized immediately, according to Hasenin Al-khersan, MD.

Julie Rodman, OD, MS, FAAO, discusses how optical coherence tomography angiography (OCT-A) can be used to diagnose and manage diabetic retinopathy.

Food recalls numbered 300 in 2024, indicating that increased vigilance may be required from both consumers and the FDA.

I. Benjamin Gaddie, OD, FAAO, summarized the best forms of treating and managing demodex blepharitis.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The Braidwood Management v Becerra decision could require payers to step up to continue covering preventive services, depending on the decision, according to Richard Hughes IV, JD, MPH.

Julie Rodman, OD, MS, FAAO, previewed the Southeastern Educational Congress of Optometry (SECO) 2025 meeting by speaking about her keynote session.

Reducing the number of intravitreal injections to treat age-related macular degeneration (AMD) is a top priority in current treatment research, says Paul Hahn, MD, PhD.

Perfluorohexyloctane ophthalmic solution had high treatment satisfaction in those who took it for dry eye.

Adolescents who are treatment-naive had promising results when using dolutegravir/lamivudine as antiretroviral therapy over 48 weeks.

The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.

Knowing the risk factors of age-related macular degeneration (AMD) and consulting an ophthalmologist or optometrist can help to maintain vision, says Hasenin Al-khersan, MD.

Engaging migrants in HIV care can help to meet the United Nations’ 95-95-95 goal in Australia.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Increasing testing for both HIV and sexually transmitted infections (STIs) can help to mitigate the incidence of both in high school students.

The House budget includes cutting $880 billion from programs under the House Energy and Commerce Committee's jurisdiction, which include Medicaid.

The upcoming Supreme Court hearing on Braidwood Management v Becerra could affect how preventive services are covered by both public and private insurance.

Black individuals had a 2-fold risk of cancer death related to prostate, myeloma, and stomach cancers compared with White individuals.

Paul Hahn, MD, PhD, discussed signs and symptoms of age-related macular degeneration (AMD) during AMD Awareness Month.

HIV infections and deaths would increase dramatically should the United States cut back on funding for the President’s Emergency Plan for AIDS Relief (PEPFAR).

An overall increase in life expectancy was observed across all individuals living with HIV but disparities between gender groups persist.

Patients with varying stages of glaucoma saw no significant difference in outcomes between standard and enhanced monofocal intraocular lenses.